Endotoxins and cytokines during liver transplantation: Changes in plasma levels and effects on clinical outcome
暂无分享,去创建一个
[1] P. Boros,et al. Differential contribution of graft and recipient to perioperative TNF-alpha, IL-1 beta, IL-6 and IL-8 levels and correlation with early graft function in clinical liver transplantation. , 1997, Clinical transplantation.
[2] P. Neuhaus,et al. Systemic liberation of interleukin-1β and interleukin-1 receptor antagonist in the perioperative phase of liver transplantation , 1996, Transplant international : official journal of the European Society for Organ Transplantation.
[3] S. Willatts,et al. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. , 1996, Critical care medicine.
[4] H. Sankary,et al. Do splanchnic viscera contribute to liver preservation reperfusion injury? , 1996, Transplantation.
[5] M. Haller,et al. Perioperative mucosal pH and splanchnic endotoxin concentration in orthotopic liver transplantation. , 1996, British journal of anaesthesia.
[6] S. Blanot,et al. Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation. , 1995, Transplantation.
[7] D. Mathieu,et al. The effects of donor and recipient endotoxemia on TNF alpha production and mortality in the rat model of syngenic orthotopic liver transplantation. , 1995, Transplantation.
[8] M. Mittlböck,et al. Tumour necrosis factor-alpha and interleukin-6: early indicators of bacterial infection after human orthotopic liver transplantation. , 1995, The European journal of surgery = Acta chirurgica.
[9] P. Kragsbjerg,et al. Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations. , 1995, The European journal of surgery = Acta chirurgica.
[10] L. Moldawer,et al. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation. , 1994, Journal of the American College of Surgeons.
[11] E. Roth,et al. TRANSHEPATIC METABOLISM OF TNF-α, IL‐6, AND ENDOTOXIN IN THE EARLY HEPATIC REPERFUSION PERIOD AFTER HUMAN LIVER TRANSPLANTATION , 1994, Transplantation.
[12] G. Dedoussis,et al. Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery. , 1994, Clinical immunology and immunopathology.
[13] T. Ishiko,et al. Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. , 1994, Cytokine.
[14] J. Bion,et al. Selective decontamination of the digestive tract reduces Gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation , 1994, Critical care medicine.
[15] J. Hurley,et al. Endotoxin and tumor necrosis factor levels and hemodynamics during human liver transplantation. , 1993, Transplantation proceedings.
[16] M. Stegall,et al. Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.
[17] J. Vincent,et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. , 1993, Chest.
[18] L. W. Andersen,et al. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor‐α concentrations in patients undergoing cardiopulmonary bypass , 1993, Critical care medicine.
[19] E. Schiff,et al. Activated cytokine pattern in hepatorenal syndrome: fall in levels after successful orthotopic liver transplantation. , 1993, Transplantation proceedings.
[20] D. V. van Thiel,et al. FK 506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion. , 1993, Journal of hepatology.
[21] H. Fusamoto,et al. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat , 1992, Hepatology.
[22] H. Tilg,et al. Serum levels of cytokines in chronic liver diseases. , 1992, Gastroenterology.
[23] P. Clavien,et al. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. , 1992, Transplantation.
[24] H. Büller,et al. Effects on leukocytes after injection of tumor necrosis factor into healthy humans , 1992 .
[25] A. Lienhart,et al. Tumor necrosis factor-α in liver transplantation and resection: No evidence for a key role in ischemia-reperfusion injury , 1992 .
[26] S. Hofbauer,et al. Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients. , 1991, Immunobiology.
[27] R. Steininger,et al. Intraoperative estimation of endotoxin, TNF alpha, and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection. , 1991, Transplantation.
[28] R. Auckenthaler,et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. , 1991, The American review of respiratory disease.
[29] T. Starzl,et al. EFFECT OF COLD ISCHEMIA TIME ON THE EARLY OUTCOME OF HUMAN HEPATIC ALLOGRAFTS PRESERVED WITH UW SOLUTION , 1991, Transplantation.
[30] A. D. de Vos,et al. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. , 1991, Journal of immunological methods.
[31] J. Lemasters,et al. Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion , 1991, Hepatology.
[32] H. Büller,et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways , 1990 .
[33] M. Salter,et al. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. , 1990, Biochemical and biophysical research communications.
[34] R. Strieter,et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.
[35] T. Starzl,et al. ENDOTOXAEMIA, PULMONARY COMPLICATIONS, AND THROMBOCYTOPENIA IN LIVER TRANSPLANTATION , 1989, The Lancet.
[36] R. Pichlmayr,et al. LIGNOCAINE METABOLITE FORMATION AS A MEASURE OF PRE-TRANSPLANT LIVER FUNCTION , 1989, The Lancet.
[37] S. Heptinstall,et al. RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION , 1988, The Lancet.
[38] P. Nowell,et al. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. , 1988, The Journal of clinical investigation.
[39] A. Waage. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. , 1987, Clinical immunology and immunopathology.
[40] J. Najarian,et al. Liver Allograft Rejection : An Analysis of the Use of Biopsy in Determining Outcome of Rejection , 1987, The American journal of surgical pathology.
[41] James Dg. Letter: Dangerous Australian antigens. , 1975 .
[42] T. Starzl,et al. Experience in hepatic transplantation , 1969 .